Key terms
About CELC
Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CELC news
Apr 12
6:07am ET
Celcuity: A Promising Buy in Healthcare Innovation and Personalized Oncology Solutions
Apr 03
12:06am ET
Celcuity (NASDAQ:CELC): A Biotech with Game-Changing Blockbuster Potential
Mar 29
2:01am ET
Celcuity Inc.’s Balancing Act: Navigating Financial Risks in Capital Raising Endeavors
Mar 28
9:10am ET
Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT)
Mar 28
9:04am ET
Celcuity price target raised to $25 from $20 at Craig-Hallum
Mar 28
8:15am ET
Gedatolisib’s Promising Clinical Trial Performance and Market Potential Justify Buy Rating
Mar 28
6:55am ET
Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)
Mar 28
6:21am ET
Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Erasca (ERAS)
Mar 28
6:00am ET
Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)
Mar 27
4:05pm ET
Celcuity reports Q4 adjusted EPS (61c), consensus (73c)
Feb 23
9:03am ET
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Celcuity (CELC)
Feb 22
4:08pm ET
Celcuity announces first patient dosed in Phase 1b/2 CELC-G-201 clinical trial
Feb 22
9:51am ET
DoorDash upgraded, Wendyâs downgraded: Wall Street’s top analyst calls
Feb 21
4:10pm ET
Celcuity initiated with a Buy at Stifel
Feb 20
7:15am ET
Celcuity appoints Mayer as Chief Commercial Officer
No recent press releases are available for CELC
CELC Financials
Key terms
Ad Feedback
CELC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CELC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range